The top three focused molecules are TGF-beta, NF-kappa-B, and beta-catenin, and the most common diseases involved in studies on SMAD7 include breast cancer, colorectal cancer, and hepatocellular carcinoma. This evidence concerns the gene SMAD7 and breast cancer.